ES2721662T3 - Proceso para la preparación de travoprost - Google Patents

Proceso para la preparación de travoprost Download PDF

Info

Publication number
ES2721662T3
ES2721662T3 ES12816098T ES12816098T ES2721662T3 ES 2721662 T3 ES2721662 T3 ES 2721662T3 ES 12816098 T ES12816098 T ES 12816098T ES 12816098 T ES12816098 T ES 12816098T ES 2721662 T3 ES2721662 T3 ES 2721662T3
Authority
ES
Spain
Prior art keywords
formula
see
compound
travoprost
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12816098T
Other languages
English (en)
Inventor
Zsuzsanna Kardos
Tibor Kiss
István Laszlofi
Irén Hortobagyi
Zoltán Bischof
Adám Bodis
Gábor Havasi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Application granted granted Critical
Publication of ES2721662T3 publication Critical patent/ES2721662T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un proceso para la preparación de travoprost de fórmula (I). **(Ver fórmula)** que comprende que el compuesto de fórmula (II) **(Ver fórmula)** se reduzca estereoselectivamente, el compuesto resultante de fórmula (III) **(Ver fórmula)** si se desea, se cristalice, el grupo lactona del compuesto de fórmula (III) se reduzca, el grupo protector p-fenilbenzoílo del compuesto así obtenido de fórmula (IV) **(Ver fórmula)** se elimine, el triol resultante de fórmula (V) **(Ver fórmula)** se transforme, si se desea después de la cristalización mediante reacción de Wittig en el ácido de fórmula (VI), **(Ver fórmula)** que después se esterifica.
ES12816098T 2011-12-21 2012-12-10 Proceso para la preparación de travoprost Active ES2721662T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1100701A HU231203B1 (hu) 2011-12-21 2011-12-21 Új eljárás travoprost előállítására
PCT/HU2012/000132 WO2013093528A1 (en) 2011-12-21 2012-12-10 Process for the preparation of travoprost

Publications (1)

Publication Number Publication Date
ES2721662T3 true ES2721662T3 (es) 2019-08-02

Family

ID=89990547

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12816098T Active ES2721662T3 (es) 2011-12-21 2012-12-10 Proceso para la preparación de travoprost

Country Status (19)

Country Link
US (2) US9212125B2 (es)
EP (1) EP2802562B1 (es)
JP (1) JP6174040B2 (es)
KR (1) KR102027889B1 (es)
CN (1) CN103998423B (es)
BR (1) BR112014014060A2 (es)
CA (1) CA2859923C (es)
ES (1) ES2721662T3 (es)
HK (1) HK1198584A1 (es)
HU (1) HU231203B1 (es)
IL (1) IL232625B (es)
IN (1) IN2014CN03482A (es)
MX (1) MX2014007684A (es)
PL (1) PL2802562T3 (es)
RU (1) RU2631316C2 (es)
TR (1) TR201905687T4 (es)
TW (1) TWI640500B (es)
WO (1) WO2013093528A1 (es)
ZA (1) ZA201404440B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2723714T3 (pl) * 2011-06-02 2018-02-28 CHINOIN Zrt. Nowe sposoby otrzymywania amidów prostaglandyn
US9115109B2 (en) * 2013-08-15 2015-08-25 Chirogate International Inc. Processes and intermediates for the preparations of isomer free prostaglandins
HU231214B1 (hu) * 2014-03-13 2021-11-29 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás nagytisztaságú prosztaglandinok előállítására
US11458041B2 (en) 2015-10-08 2022-10-04 Ocular Therapeutix, Inc. Punctal plug and bioadhesives
EP3950672A4 (en) * 2019-03-27 2023-01-11 Kyowa Pharma Chemical Co., Ltd. PROCESS FOR PRODUCTION OF PROSTAGLANDIN
US20210251893A1 (en) 2020-02-06 2021-08-19 Ocular Therapeutix, Inc. Compositions and Methods for Treating Ocular Diseases
EP4261206A1 (en) * 2020-12-23 2023-10-18 Kyowa Pharma Chemical Co., Ltd. Method for separating geometrical isomer
CN114671906B (zh) * 2020-12-24 2024-03-15 武汉武药制药有限公司 制备曲伏前列素中间体的方法
CN115806517A (zh) * 2022-12-21 2023-03-17 上海彩迩文生化科技有限公司 一种高纯度地诺***素的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2328131C3 (de) * 1973-05-30 1986-11-13 Schering AG, 1000 Berlin und 4709 Bergkamen Neues Verfahren zur Herstellung von Prostaglandin-F↓2↓↓α↓ und seinen Analogen
HU184948B (en) * 1981-04-14 1984-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 5-substituted 4-oxo-pgi down 1 derivatives
HU190007B (en) 1982-05-06 1986-08-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for producing new aromatic prostacylin analogues
CS239696B1 (cs) * 1984-05-03 1986-01-16 Jiri Hajek Způsob dělení 15S-a 15R-isomerů 4-/4-/substituovaných X-fenoxy/-3-hydroxy-1butenyí/hexahydro-5-hydroxy- -2H-cyklopenta[b]furan-2-onů
HU212570B (en) * 1991-06-24 1996-08-29 Chinoin Gyogyszer Es Vegyeszet Process for producing 13,14-dihydro-15(r)-17-phenyl-18,19,20-trinor-pgf2alfa-isopropylester
US5510383A (en) 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US7166730B2 (en) * 2000-01-27 2007-01-23 Fine Tech Laboratories, Ltd Process for the preparation of prostaglandin derivatives
GB0112699D0 (en) * 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
GB0329379D0 (en) * 2003-12-19 2004-01-21 Johnson Matthey Plc Prostaglandin synthesis
UA84726C2 (ru) * 2004-01-05 2008-11-25 Никокс С.А. Производные простагландинов, способ их получения, фармацевтическая композиция (варианты) и способ лечения глаукомы или гипертензии глаза
EP2143712A1 (en) * 2008-07-10 2010-01-13 Sandoz AG Improved Process for the Production of Prostaglandins and Prostaglandin Analogs
IT1393112B1 (it) * 2009-02-27 2012-04-11 Sifavitor S R L Procedimento per la preparazione di derivati di prostaglandine
US8901319B2 (en) 2009-10-16 2014-12-02 Cayman Chemical Company, Incorporated Process for the preparation of F-series prostaglandins
CA2777352A1 (en) * 2009-11-05 2011-05-12 Biocon Limited A novel process for the preparation of prostaglandins and intermediates thereof
EP2495235B1 (en) 2011-03-04 2015-08-05 Newchem S.p.A. Process for the synthesis of prostaglandins and intermediates thereof
PL2723714T3 (pl) 2011-06-02 2018-02-28 CHINOIN Zrt. Nowe sposoby otrzymywania amidów prostaglandyn

Also Published As

Publication number Publication date
MX2014007684A (es) 2014-07-28
EP2802562A1 (en) 2014-11-19
IN2014CN03482A (es) 2015-07-03
US9212125B2 (en) 2015-12-15
HK1198584A1 (en) 2015-04-30
TW201336816A (zh) 2013-09-16
IL232625B (en) 2019-03-31
TWI640500B (zh) 2018-11-11
EP2802562B1 (en) 2019-01-23
RU2014129492A (ru) 2016-02-10
BR112014014060A2 (pt) 2017-06-13
CN103998423A (zh) 2014-08-20
HU231203B1 (hu) 2021-10-28
ZA201404440B (en) 2015-12-23
KR20140107541A (ko) 2014-09-04
US20160137621A1 (en) 2016-05-19
HUP1100701A2 (en) 2013-07-29
WO2013093528A1 (en) 2013-06-27
KR102027889B1 (ko) 2019-10-04
US20140343299A1 (en) 2014-11-20
PL2802562T3 (pl) 2019-08-30
CA2859923C (en) 2020-11-24
JP6174040B2 (ja) 2017-08-02
CN103998423B (zh) 2018-04-27
CA2859923A1 (en) 2013-06-27
RU2631316C2 (ru) 2017-09-21
IL232625A0 (en) 2014-06-30
TR201905687T4 (tr) 2019-05-21
JP2015506343A (ja) 2015-03-02

Similar Documents

Publication Publication Date Title
ES2721662T3 (es) Proceso para la preparación de travoprost
UY32142A (es) Preparación de una quinoliniloxidifenilciclopropanodicarboxamida
EA201500173A1 (ru) Фунгицидные композиции
MX2015005286A (es) Procedimiento para la preparación de derivados del ácido biliar.
CU24354B1 (es) Procedimiento de obtención de derivados de tetrafluoropropilmorfolina
UY31523A1 (es) Procedimiento para la preparacion de esteres alquilicos de acidos grasos
BRPI0817747A8 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
CL2011000296A1 (es) Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados.
MX2017011407A (es) Metodo para producir esteres de tetrahidropiranilo.
IN2014DN00144A (es)
AR125817A2 (es) Utilización de ácido sulfónico para la recuperación de glicerol procedente de la reacción de transesterificación de triglicéridos
MX342273B (es) Proceso para la preparacion de esteres de acido (5-fluoro-2-metil-3-quinolina-2-ilmetil-indol-1-il)-acetico.
IN2014MN00971A (es)
WO2014087208A3 (en) A process of preparing alcaftadine
MX2014004688A (es) Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos.
EP4282973A3 (en) Processes for the preparation of pyrimidinylcyclopentane compounds
CO7030967A2 (es) Método para preparar un compuesto mediante la reacción de adición de michael novedosa usando agua o varios ácidos como aditivo
CU24311B1 (es) Método de preparación de compuestos alfa-galactosil ceramidas
WO2014068599A3 (en) Process for pralatrexate
WO2014170345A3 (en) Method for improved utilization of the production potential of transgenic plants involving the application of a phthaldiamide derivative
MX369283B (es) Preparacion de 2-amino-5-ciano-n, 3-dimetilbenzamida.
NZ711329A (en) A process for preparation of (2s, 5r)- sulfuric acid mono-{ [(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester
MY185155A (en) Polyhydroxyalkanoate derivatives, preparation and uses thereof
BR112015002189A2 (pt) método multiestágio para preparar sais de metal alcalino de ésteres 4-hidroxi-2-oxo-2,5-dihidrofurano-3-carboxílicos específicos
BR112014000613A2 (pt) método para a preparação de ácido ciclo-hexanocarboxílico